Role of lipid-lowering therapy in peripheral artery disease
Atherosclerosis is a multifactorial, lipoprotein-driven condition that leads to plaque formation
within the arterial tree, leading to subsequent arterial stenosis and thrombosis that accounts …
within the arterial tree, leading to subsequent arterial stenosis and thrombosis that accounts …
Statins and renal cell carcinoma: Antitumor activity and influence on cancer risk and survival
M Santoni, FSM Monteiro, F Massari… - Critical Reviews in …, 2022 - Elsevier
Statins are commonly prescribed to reduce plasma cholesterol levels and risk of
cardiovascular events and mortality. Statin exposure may have cancer-preventive properties …
cardiovascular events and mortality. Statin exposure may have cancer-preventive properties …
[PDF][PDF] Peripheral vascular disease
A MOA, A MOA, FC Tablet, MR Tablet… - PHA …, 2023 - pha2024.netheadinfotech.net
▪ INDICATIONS AND DOSE To reduce the rate of aortic dilatation in aortic aneurysm
(atherosclerotic, Marfan syndrome) and in Loeys-Dietz syndrome5| Thoracic aortic …
(atherosclerotic, Marfan syndrome) and in Loeys-Dietz syndrome5| Thoracic aortic …
The potential role of antioxidants in the treatment of peripheral arterial disease: a systematic review
Peripheral arterial disease (PAD) has a worldwide prevalence and is a significant cause of
cardiovascular morbidity and mortality. Due to its high prevalence and higher rates of …
cardiovascular morbidity and mortality. Due to its high prevalence and higher rates of …
Peripheral Artery Disease: Overview of Diagnosis and Medical Therapy
M Bierowski, T Galanis, A Majeed, A Mofid - Medical Clinics, 2023 - medical.theclinics.com
The worldwide prevalence of peripheral artery disease (PAD) is estimated to be 5% with
approximately 230 million people affected by this disease globally. 1 In the United States, at …
approximately 230 million people affected by this disease globally. 1 In the United States, at …
Diabetic dyslipidemia impairs coronary collateral formation: an update
Y Shen, XQ Wang, Y Dai, YX Wang… - Frontiers in …, 2022 - frontiersin.org
Coronary collateralization is substantially impaired in patients with type 2 diabetes and
occlusive coronary artery disease, which leads to aggravated myocardial ischemia and a …
occlusive coronary artery disease, which leads to aggravated myocardial ischemia and a …
Role of the advanced nurse practitioner within the vascular team: A qualitative study of vascular physicians and nurses
T Kubiak, J Sitruk, A Durivage, L Khider… - Frontiers in Public …, 2023 - frontiersin.org
Objective To assess the perception of Advanced Nurse Practitioners (ANP) by physicians
and nurses in vascular medicine. As the status of ANP in France was recently enacted by …
and nurses in vascular medicine. As the status of ANP in France was recently enacted by …
[HTML][HTML] Detection, management, and prevention of diabetes-related foot disease in the Australian context
S McNeil, K Waller, YSP Lorenzo… - World Journal of …, 2023 - ncbi.nlm.nih.gov
Diabetes-related foot disease (DFD) is a widely feared complication among people who live
with diabetes. In Australia and globally, rates of disability, cardio-vascular disease, lower …
with diabetes. In Australia and globally, rates of disability, cardio-vascular disease, lower …
Ischemic cardio-cerebrovascular disease and all-cause mortality in Chinese elderly patients: a propensity-score matching study
Q Yang, S Sun, LB Cui, S Gao, Z Gu, Z Fang… - European Journal of …, 2024 - Springer
Background Ischemic cardio-cerebrovascular disease is the leading cause of mortality
worldwide. However, studies focusing on elderly and very elderly patients are scarce …
worldwide. However, studies focusing on elderly and very elderly patients are scarce …
[HTML][HTML] Protective effects of statins on limb and cardiovascular outcomes in patients with peripheral artery disease and end-stage renal disease
CR Lu, SY Lu, SY Lin, HT Yip, CH Liu… - Acta Cardiologica …, 2023 - ncbi.nlm.nih.gov
Background Previous studies have reported that statins have inconsistent and marginal
cardiovascular (CV) benefits in patients with end-stage renal disease (ESRD). However …
cardiovascular (CV) benefits in patients with end-stage renal disease (ESRD). However …